Key result
Novel nomogram predicts adverse outcomes in normotensive acute PE with an AUC of ~0.93.
Why the study?
It is important to identify deterioration in normotensive patients with acute pulmonary embolism on admission to improve risk stratification.
Can a risk-scoring tool accurately predict deterioration within 30 days in normotensive patients with acute pulmonary embolism?
Cohort (n=845)
No
Can a risk-scoring tool accurately predict deterioration within 30 days in normotensive patients with acute pulmonary embolism?
A novel web-based nomogram incorporating clinical, laboratory, and CT parameters accurately predicts 30-day deterioration in normotensive patients with acute pulmonary embolism.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in normotensive PE; hypothesis-generating pending prospective validation.
Background: It is important to identify deterioration in normotension patients with acute pulmonary embolism (PE). This study aimed to develop a tool for predicting deterioration among normotensive patients with acute PE on admission.Methods: Clinical, laboratory, and computed tomography parameters were retrospective collected for normotension patients with acute PE who were treated at a Chinese center from January 2011 to May 2020 on admission into hospital. The endpoint of the deterioration was any adverse outcome within 30 days. The eligible patients were randomized 2:1 to training and validation datasets. A nomogram was developed and validated by training and validation datasets respectively. The areas under the receiver operating characteristic curves (AUCs) and 95% confidence intervals (CIs) were calculated. A risk-scoring tool for predicting deterioration was applied as a web-based calculator.Results: The 845 eligible patients (420 men, 425 women) had an average age of 60.05±15.43 years. Adverse outcomes were identified for 81 patients (9.6%). The nomogram for adverse outcomes included heart rate, systolic pressure, N-terminal-pro brain natriuretic peptide, and ventricular/atrial diameter ratios at 4-chamber view, which provided AUC values of 0.925 in the training dataset (95% CI: 0.900–0.946, p<0.001) and 0.900 in the validation dataset (95% CI: 0.883–0.948, p<0.001). A risk-scoring tool was published as a web-based calculator (https://gaoyzcmu.shinyapps.io/APE9AD/).Conclusions: We developed a web-based scoring tool that may help predict deterioration in normotensive patients with acute PE.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2020) conducted a cohort in Acute pulmonary embolism (n=845). Nomogram risk-scoring tool vs. Bova score and 2019 ESC algorithm was evaluated on Adverse outcomes within 30 days (AUC 0.925, 95% CI 0.900-0.946, p=<0.001). A novel nomogram incorporating heart rate, systolic pressure, NT-pro BNP, and ventricular/atrial diameter ratios accurately predicted 30-day adverse outcomes in normotensive acute pulmonary embolism with an AUC of 0.925.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: